早産治療の世界市場（～2026年）

• 英文タイトル：Global Premature Labor Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04356
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は早産治療のグローバル市場について調査・分析したレポートです。種類別（プロゲステロン、OBE-022、レトシバン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別早産治療の競争状況、市場シェア
・世界の早産治療市場：種類別市場規模 2015年-2020年（プロゲステロン、OBE-022、レトシバン、その他）
・世界の早産治療市場：種類別市場規模予測 2021年-2026年（プロゲステロン、OBE-022、レトシバン、その他）
・世界の早産治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他）
・世界の早産治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他）
・北米の早産治療市場分析：米国、カナダ
・ヨーロッパの早産治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの早産治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の早産治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの早産治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：AMAG Pharmaceuticals Inc、GlaxoSmithKline Plc、Juniper Pharmaceuticals Inc、Kissei Pharmaceutical Co Ltd、Lipocine Inc、ObsEva SA
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Premature Labor Treatment Market
The global Premature Labor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Premature Labor Treatment Scope and Market Size
Premature Labor Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Premature Labor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AMAG Pharmaceuticals Inc
GlaxoSmithKline Plc
Juniper Pharmaceuticals Inc
Kissei Pharmaceutical Co Ltd
Lipocine Inc
ObsEva SA
…

Market segment by Type, the product can be split into
Progesterone
OBE-022
Retosiban
Others
Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Premature Labor Treatment Revenue
1.4 Market by Type
1.4.1 Global Premature Labor Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Progesterone
1.4.3 OBE-022
1.4.4 Retosiban
1.4.5 Others
1.5 Market by Application
1.5.1 Global Premature Labor Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Premature Labor Treatment Market Perspective (2015-2026)
2.2 Global Premature Labor Treatment Growth Trends by Regions
2.2.1 Premature Labor Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Premature Labor Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Premature Labor Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Premature Labor Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Premature Labor Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Premature Labor Treatment Players by Market Size
3.1.1 Global Top Premature Labor Treatment Players by Revenue (2015-2020)
3.1.2 Global Premature Labor Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Premature Labor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Premature Labor Treatment Market Concentration Ratio
3.2.1 Global Premature Labor Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Premature Labor Treatment Revenue in 2019
3.3 Premature Labor Treatment Key Players Head office and Area Served
3.4 Key Players Premature Labor Treatment Product Solution and Service
3.5 Date of Enter into Premature Labor Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Premature Labor Treatment Historic Market Size by Type (2015-2020)
4.2 Global Premature Labor Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Premature Labor Treatment Market Size by Application (2015-2020)
5.2 Global Premature Labor Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Premature Labor Treatment Market Size (2015-2020)
6.2 Premature Labor Treatment Key Players in North America (2019-2020)
6.3 North America Premature Labor Treatment Market Size by Type (2015-2020)
6.4 North America Premature Labor Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Premature Labor Treatment Market Size (2015-2020)
7.2 Premature Labor Treatment Key Players in Europe (2019-2020)
7.3 Europe Premature Labor Treatment Market Size by Type (2015-2020)
7.4 Europe Premature Labor Treatment Market Size by Application (2015-2020)

8 China
8.1 China Premature Labor Treatment Market Size (2015-2020)
8.2 Premature Labor Treatment Key Players in China (2019-2020)
8.3 China Premature Labor Treatment Market Size by Type (2015-2020)
8.4 China Premature Labor Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Premature Labor Treatment Market Size (2015-2020)
9.2 Premature Labor Treatment Key Players in Japan (2019-2020)
9.3 Japan Premature Labor Treatment Market Size by Type (2015-2020)
9.4 Japan Premature Labor Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Premature Labor Treatment Market Size (2015-2020)
10.2 Premature Labor Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Premature Labor Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Premature Labor Treatment Market Size by Application (2015-2020)

11 India
11.1 India Premature Labor Treatment Market Size (2015-2020)
11.2 Premature Labor Treatment Key Players in India (2019-2020)
11.3 India Premature Labor Treatment Market Size by Type (2015-2020)
11.4 India Premature Labor Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Premature Labor Treatment Market Size (2015-2020)
12.2 Premature Labor Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Premature Labor Treatment Market Size by Type (2015-2020)
12.4 Central & South America Premature Labor Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AMAG Pharmaceuticals Inc
13.1.1 AMAG Pharmaceuticals Inc Company Details
13.1.2 AMAG Pharmaceuticals Inc Business Overview
13.1.3 AMAG Pharmaceuticals Inc Premature Labor Treatment Introduction
13.1.4 AMAG Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2015-2020))
13.1.5 AMAG Pharmaceuticals Inc Recent Development
13.2 GlaxoSmithKline Plc
13.2.1 GlaxoSmithKline Plc Company Details
13.2.2 GlaxoSmithKline Plc Business Overview
13.2.3 GlaxoSmithKline Plc Premature Labor Treatment Introduction
13.2.4 GlaxoSmithKline Plc Revenue in Premature Labor Treatment Business (2015-2020)
13.2.5 GlaxoSmithKline Plc Recent Development
13.3 Juniper Pharmaceuticals Inc
13.3.1 Juniper Pharmaceuticals Inc Company Details
13.3.2 Juniper Pharmaceuticals Inc Business Overview
13.3.3 Juniper Pharmaceuticals Inc Premature Labor Treatment Introduction
13.3.4 Juniper Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2015-2020)
13.3.5 Juniper Pharmaceuticals Inc Recent Development
13.4 Kissei Pharmaceutical Co Ltd
13.4.1 Kissei Pharmaceutical Co Ltd Company Details
13.4.2 Kissei Pharmaceutical Co Ltd Business Overview
13.4.3 Kissei Pharmaceutical Co Ltd Premature Labor Treatment Introduction
13.4.4 Kissei Pharmaceutical Co Ltd Revenue in Premature Labor Treatment Business (2015-2020)
13.4.5 Kissei Pharmaceutical Co Ltd Recent Development
13.5 Lipocine Inc
13.5.1 Lipocine Inc Company Details
13.5.2 Lipocine Inc Business Overview
13.5.3 Lipocine Inc Premature Labor Treatment Introduction
13.5.4 Lipocine Inc Revenue in Premature Labor Treatment Business (2015-2020)
13.5.5 Lipocine Inc Recent Development
13.6 ObsEva SA
13.6.1 ObsEva SA Company Details
13.6.2 ObsEva SA Business Overview
13.6.3 ObsEva SA Premature Labor Treatment Introduction
13.6.4 ObsEva SA Revenue in Premature Labor Treatment Business (2015-2020)
13.6.5 ObsEva SA Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Premature Labor Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Premature Labor Treatment Revenue
Table 3. Ranking of Global Top Premature Labor Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Premature Labor Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Progesterone
Table 6. Key Players of OBE-022
Table 7. Key Players of Retosiban
Table 8. Key Players of Others
Table 9. Global Premature Labor Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Premature Labor Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Premature Labor Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Premature Labor Treatment Market Share by Regions (2015-2020)
Table 13. Global Premature Labor Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Premature Labor Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Premature Labor Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Premature Labor Treatment Players
Table 20. Global Premature Labor Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Premature Labor Treatment Market Share by Players (2015-2020)
Table 22. Global Top Premature Labor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premature Labor Treatment as of 2019)
Table 23. Global Premature Labor Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Premature Labor Treatment Product Solution and Service
Table 26. Date of Enter into Premature Labor Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Premature Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Premature Labor Treatment Market Size Share by Type (2015-2020)
Table 30. Global Premature Labor Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Premature Labor Treatment Market Size Share by Application (2015-2020)
Table 32. Global Premature Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Premature Labor Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Premature Labor Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Premature Labor Treatment Market Share (2019-2020)
Table 36. North America Premature Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Premature Labor Treatment Market Share by Type (2015-2020)
Table 38. North America Premature Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Premature Labor Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Premature Labor Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Premature Labor Treatment Market Share (2019-2020)
Table 42. Europe Premature Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Premature Labor Treatment Market Share by Type (2015-2020)
Table 44. Europe Premature Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Premature Labor Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Premature Labor Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Premature Labor Treatment Market Share (2019-2020)
Table 48. China Premature Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Premature Labor Treatment Market Share by Type (2015-2020)
Table 50. China Premature Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Premature Labor Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Premature Labor Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Premature Labor Treatment Market Share (2019-2020)
Table 54. Japan Premature Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Premature Labor Treatment Market Share by Type (2015-2020)
Table 56. Japan Premature Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Premature Labor Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Premature Labor Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Premature Labor Treatment Market Share (2019-2020)
Table 60. Southeast Asia Premature Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Premature Labor Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Premature Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Premature Labor Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Premature Labor Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Premature Labor Treatment Market Share (2019-2020)
Table 66. India Premature Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Premature Labor Treatment Market Share by Type (2015-2020)
Table 68. India Premature Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Premature Labor Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Premature Labor Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Premature Labor Treatment Market Share (2019-2020)
Table 72. Central & South America Premature Labor Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Premature Labor Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Premature Labor Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Premature Labor Treatment Market Share by Application (2015-2020)
Table 76. AMAG Pharmaceuticals Inc Company Details
Table 77. AMAG Pharmaceuticals Inc Business Overview
Table 78. AMAG Pharmaceuticals Inc Product
Table 79. AMAG Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2015-2020) (Million US$)
Table 80. AMAG Pharmaceuticals Inc Recent Development
Table 81. GlaxoSmithKline Plc Company Details
Table 82. GlaxoSmithKline Plc Business Overview
Table 83. GlaxoSmithKline Plc Product
Table 84. GlaxoSmithKline Plc Revenue in Premature Labor Treatment Business (2015-2020) (Million US$)
Table 85. GlaxoSmithKline Plc Recent Development
Table 86. Juniper Pharmaceuticals Inc Company Details
Table 87. Juniper Pharmaceuticals Inc Business Overview
Table 88. Juniper Pharmaceuticals Inc Product
Table 89. Juniper Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2015-2020) (Million US$)
Table 90. Juniper Pharmaceuticals Inc Recent Development
Table 91. Kissei Pharmaceutical Co Ltd Company Details
Table 92. Kissei Pharmaceutical Co Ltd Business Overview
Table 93. Kissei Pharmaceutical Co Ltd Product
Table 94. Kissei Pharmaceutical Co Ltd Revenue in Premature Labor Treatment Business (2015-2020) (Million US$)
Table 95. Kissei Pharmaceutical Co Ltd Recent Development
Table 96. Lipocine Inc Company Details
Table 97. Lipocine Inc Business Overview
Table 98. Lipocine Inc Product
Table 99. Lipocine Inc Revenue in Premature Labor Treatment Business (2015-2020) (Million US$)
Table 100. Lipocine Inc Recent Development
Table 101. ObsEva SA Company Details
Table 102. ObsEva SA Business Overview
Table 103. ObsEva SA Product
Table 104. ObsEva SA Revenue in Premature Labor Treatment Business (2015-2020) (Million US$)
Table 105. ObsEva SA Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Premature Labor Treatment Market Share by Type: 2020 VS 2026
Figure 2. Progesterone Features
Figure 3. OBE-022 Features
Figure 4. Retosiban Features
Figure 5. Others Features
Figure 6. Global Premature Labor Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Premature Labor Treatment Report Years Considered
Figure 11. Global Premature Labor Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Premature Labor Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Premature Labor Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Premature Labor Treatment Market Share by Players in 2019
Figure 16. Global Top Premature Labor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premature Labor Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Premature Labor Treatment Revenue in 2019
Figure 18. North America Premature Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Premature Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Premature Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Premature Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Premature Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Premature Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Premature Labor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

早漏症治療の世界市場（～2026年）

Global Premature Ejaculation Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04355 2020年11月20日 90Pages
当調査資料は早漏症治療のグローバル市場について調査・分析したレポートです。種類別（シアリス、バイアグラ、レビトラ）市場規模、用途別（スーパー、病院、薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

早期陣痛治療の世界市場（～2026年）

Global Preterm Labor Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04368 2020年11月20日 99Pages
当調査資料は早期陣痛治療のグローバル市場について調査・分析したレポートです。種類別（子宮収縮抑制薬、ベータ–模倣薬、カルシウムチャネル遮断薬、NSAIDS、コルチコステロイド、硫酸マグネシウム、抗生物質）市場規模、用途別（病院、小児科および新生児クリニック、ナーシングホーム、薬局）市場規模、地域別（...

前期破水（PROM）検査の世界市場（～2026年）

Global Premature Rupture of Membranes (PROM) Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY04357 2020年11月20日 90Pages
当調査資料は前期破水（PROM）検査のグローバル市場について調査・分析したレポートです。種類別（ニトラジン/pH検査、ファーニング検査、アニシュア検査、その他）市場規模、用途別（病院、診療所、診断研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

脂質異常症治療の世界市場（～2026年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12520 2020年11月25日 92Pages
当調査資料は脂質異常症治療のグローバル市場について調査・分析したレポートです。種類別（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他薬剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

水疱性類天疱瘡治療の世界市場（～2026年）

Global Bullous Pemphigoid Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11210 2020年11月25日 91Pages
当調査資料は水疱性類天疱瘡治療のグローバル市場について調査・分析したレポートです。種類別（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬）市場規模、用途別（病院薬局、小売薬局、通信販売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本...

ナルコレプシー治療の世界市場（～2026年）

Global Narcolepsy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03907 2020年11月20日 94Pages
当調査資料はナルコレプシー治療のグローバル市場について調査・分析したレポートです。種類別（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）市場規模、用途別（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー）市場規模、...

ジフテリア治療の世界市場（～2026年）

Global Diphtheria Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11675 2020年11月25日 97Pages
当調査資料はジフテリア治療のグローバル市場について調査・分析したレポートです。種類別（破傷風免疫グロブリン、破傷風トキソイド、破傷風-ジフテリア、ジフテリアトキソイド、百日咳）市場規模、用途別（抗毒素、抗生物質、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イ...

軟骨肉腫治療の世界市場（～2026年）

Global Chondrosarcoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11355 2020年11月25日 96Pages
当調査資料は軟骨肉腫治療のグローバル市場について調査・分析したレポートです。種類別（外科的治療、化学療法、放射線療法）市場規模、用途別（病院、専門クリニック、がん治療センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

ハンセン病治療の世界市場（～2026年）

Global Leprosy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12500 2020年11月25日 93Pages
当調査資料はハンセン病治療のグローバル市場について調査・分析したレポートです。種類別（スルホン、フェナジン誘導体、抗管状薬、その他）市場規模、用途別（病院、クリニック、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

消化器疾患治療　の世界市場（～2026年）

Global Digestive Distress Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11647 2020年11月25日 96Pages
当調査資料は消化器疾患治療　のグローバル市場について調査・分析したレポートです。種類別（上部消化管、下部消化管）市場規模、用途別（病院薬局、オンライン薬局、ドラッグストア、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

早期陣痛治療の世界市場（～2026年） Preterm labor is defined as regular contractions of the uterus resulting in changes in the cervix that start before 37 weeks of pregnancy. Increase in premature birth cases and rapid increase birthrate are major driving factors of preterm labor treatment market. Market Analysis and Insights: Global …
早漏症治療の世界市場（～2026年） Premature ejaculation is one of the most common sexual dysfunctions occurring in men. A major reason for the market growth in the Americas is a significant rise in the number of premature ejaculation patients due to psychological factors such as strain and stress resulting from the ever-changing lif…
前期破水（PROM）検査の世界市場（～2026年） The premature rupture of membranes (PROM) is a condition that occurs in pregnancy. It is defined as the breakage of the amniotic sac, which generally takes place one or two hours before the onset of contractions or labor. The early breakage of the membrane, i.e. before 37 weeks of gestation, can lea…
統合失調感情障害治療の世界市場（～2026年） Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders. The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. Market Analysis and Insights: Global Schizoaffective Disorders Treatment Market Th…
巨細胞性動脈炎治療の世界市場（～2026年） Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin …